Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2004 Jan 13;18(1):36–41. doi: 10.1002/jcla.20001

Flow cytometric study of neutrophilic granulopoiesis in normal bone marrow using an expanded panel of antibodies: Correlation with morphologic assessments

M Tarek Elghetany 1,, Yimin Ge 1, Jyoti Patel 1, Joe Martinez 1, Hanna Uhrova 1
PMCID: PMC6807735  PMID: 14730556

Abstract

Flow cytometry studies of surface markers of neutrophils have been performed mostly on peripheral blood, and for a limited spectrum of diseases. Studying maturation defects on developing neutrophils in the bone marrow (BM) may be helpful in BM diseases, such as myelodysplastic syndromes and Shwachman‐Diamond syndrome. We applied an expanded panel of antibodies to examine normal maturation patterns in 26 control samples of BM together with microscopic correlation. Promyelocytes correlated well with the CD24 and CD11b populations, and metamyelocytes correlated well with the CD16+ population (intermediate positivity). An excellent correlation was also identified between the sum of bands and segmented neutrophils and each of the following: CD16++ (strong positivity), CD35+, CD87+, and CD64. Although visually identified segmented neutrophils paralleled CD10 positivity, there was an appreciable difference between both methods. We conclude that neutrophilic granulocyte maturation in the BM is accompanied by a change in surface antigens that reflects certain stages of development. A successful strategy for detecting maturation defects is to include several antibodies that are known to be expressed or absent at the same stage of maturation, such as CD16, CD35, CD64, and CD87. J. Clin. Lab. Anal. 18:36–41, 2004. © 2004 Wiley‐Liss, Inc.

Keywords: Key words, granulocytes, neutrophils, CD antigens, maturation, surface antigens

REFERENCES

  • 1. Anderson DC, Springer TA. Leukocyte adhesion deficiency: an inherited defect in the Mac‐1, LFA‐1, and p150,95. Ann Rev Med 1987;38:175–194. [DOI] [PubMed] [Google Scholar]
  • 2. Hall SE, Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemo‐globinuria. Blood 1996;87:5332–5340. [PubMed] [Google Scholar]
  • 3. Bowen KL, Davis BH. Abnormal patterns of expression of CD16 (FcRγIII) and CD11b (CRIII) antigens by developing neutrophils in the bone marrow of patients with myelodysplastic syndrome. Lab Hematol 1997;3:292–298. [Google Scholar]
  • 4. Elghetany MT. Surface marker abnormalities in myelodysplastic syndromes. Haematologica 1998;83:1104–1115. [PubMed] [Google Scholar]
  • 5. Stetler‐Stevenson M, Arthur DC, Jabbour N, et al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood 2001;98:979–987. [DOI] [PubMed] [Google Scholar]
  • 6. Elghetany MT, Martinez J, Patel J, Sackey K, Alter BP. Granulocytic surface marker abnormalities are detected only in patients with myelodysplastic syndrome and patients with Shwachman Diamond syndrome but not other bone marrow failure syndromes [Abstract]. Blood 2000;98(suppl 2000;98(suppl)327A. [Google Scholar]
  • 7. Elghetany MT, Molina CP, Patel J, Martinez J, Schwab H, Velagaleti GVN. Expression of CD4 on peripheral blood granulocytes in a case of myelodysplastic syndrome in association with translocation (5;12). Cancer Genet Cytogenet 2002;136:38–42. [DOI] [PubMed] [Google Scholar]
  • 8. Elghetany MT. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol Dis 2002;28:260–274. [DOI] [PubMed] [Google Scholar]
  • 9. Lund‐Johansen F, Terstappen LWMM. Differential surface expression of cell adhesion molecules during granulocyte maturation. J Leukoc Biol 1993;54:47–55. [DOI] [PubMed] [Google Scholar]
  • 10. Terstappen LWMM, Safford M, Loken MR. Flow cytometric analysis of human bone marrow. III. Neutrophil maturation. Leukemia 1990;4:657–663. [PubMed] [Google Scholar]
  • 11. Terstappen LWMM, Loken MR. Myeloid cell differentiation in normal marrow and acute leukemia assessed by multi‐dimensional flow cytometry. Anal Cell Pathol 1990;2:229–240. [PubMed] [Google Scholar]
  • 12. Terstappen LWMM, Hollander Z, Meiners H, Loken MR. Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells. J Leukoc Biol 1990;48:138–148. [DOI] [PubMed] [Google Scholar]
  • 13. Elghetany MT, Patel J. Assessment of CD24 expression on bone marrow neutrophilic granulocytes: CD24 is a marker for the myelocytic stage of development. Am J Hematol 2002;71:348–349. [DOI] [PubMed] [Google Scholar]
  • 14. Elghetany MT, Patel J, Martinez J, Schwab H. CD 87 as a marker for terminal granulocytic maturation: assessment of its expression during granulopoiesis. Cytometry 2003;51B:9–13. [DOI] [PubMed] [Google Scholar]
  • 15. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocytes. Blood 1997;89:3502–3521. [PubMed] [Google Scholar]
  • 16. Kuijpers TW, Tool ATJ, van der Schoot CE, et al. Membrane surface marker antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 1991;78:1105–1111. [PubMed] [Google Scholar]
  • 17. Werfel T, Sonntag G, Weber MH, Götze O. Rapid increase in the membrane expression of neutral endopeptidase (CD10), aminopeptidase N (CD13), tyrosine phosphatase (CD45), and Fcγ‐RIII (CD16) upon stimulation of human peripheral leukocytes with human C5a. J Immunol 1991;147:3909–3914. [PubMed] [Google Scholar]
  • 18. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. Membrane glycoprotein CD36: a review of its role in adherence, signal transduction, and transfusion medicine. Blood 1992;80:1105–1115. [PubMed] [Google Scholar]
  • 19. LeBien TW, McCormack RT. The common acute lymphoblastic leukemia antigen (CD10): emancipation from a functional enigma. Blood 1989;73:625–635. [PubMed] [Google Scholar]
  • 20. Cossman J, Neckers LM, Leonard WJ, Greene WC. Polymorpho‐nuclear neutrophils express the common acute lymphoblastic antigen. J Exp Med 1983;157:1064–1069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Kansas GS, Muirhead MJ, Dailey MO. Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 molecules during normal myeloid and erythroid differentiation in humans. Blood 1990;76:2483–2492. [PubMed] [Google Scholar]
  • 22. Elghetany MT. Diagnostic utility of flow cytometric immuno‐phenotyping in myelodysplastic syndrome [Letter]. Blood 2002;99:391–392. [DOI] [PubMed] [Google Scholar]
  • 23. Moore MAS. The hematopoietic system and hematopoiesis In: Knowels DA, editor. Neoplastic hematopathology. Philadelphia: Lippincott Williams & Wilkins; 2001. p 1–42. [Google Scholar]
  • 24. Hüble W, Andert S, Thum G, Ortner S, Bayer PM. Value of neutrophil CD16 expression for detection of left shift and acute‐phase response. Am J Clin Pathol 1997;107:187–196. [DOI] [PubMed] [Google Scholar]
  • 25. Kabutomori O, Iwatani Y, Koh T, Fushimi R, Amino N. Decrease in the density of IgG‐Fc receptor III (CD16) on toxic neutrophils. Acta Haematol 1993;89:163–164. [DOI] [PubMed] [Google Scholar]
  • 26. Arnaout MA. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990;75:1037–1050. [PubMed] [Google Scholar]
  • 27. Boyd AW, Dunn SM, Fecondo JV, et al. Regulation of expression of a human intercellular adhesion molecule (ICAM‐1) during lymphohematopoietic differentiation. Blood 1989;73:1896–1903. [PubMed] [Google Scholar]
  • 28. Prall F, Nollau P, Neumaier M, et al. CD66a (BGP), an adhesion molecule of the carcinoembryonic antigen family, is expressed in epithelium, endothelium, and myeloid cells in a wide range of normal human tissue. J Histochem Cytochem 1996;44:35–41. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES